Search results for "Vaccines"
Allergy may not be absolute obstacle to COVID-19 vaccine
Allergic reactions to COVID-19 vaccines are rare but remain a source of concern. Experts at a recent conference offered some advice on management.
https://immattersacp.org/archives/2021/04/allergy-may-not-be-absolute-obstacle-to-covid-19-vaccine.htm
1 Apr 2021
Interim data find vaccine 66% to 85% effective against symptomatic RSV in older adults
The results from a large ongoing phase 3 trial show success in protection from respiratory syncytial virus (RSV)-associated lower respiratory tract illness on two important primary endpoints, although reductions in hospitalization and death have yet to be shown.
https://immattersacp.org/weekly/archives/2023/04/11/1.htm
11 Apr 2023
Hepatitis B vaccine now recommended for adults ages 19 through 59 years
The Advisory Committee on Immunization Practices has changed its guidance to encourage clinicians to offer the vaccine to adult patients, rather than target those with risk factors or wait for it to be requested.
https://immattersacp.org/weekly/archives/2022/04/05/1.htm
5 Apr 2022
Keep up with vaccine recommendations
New vaccines and their recommendations have added complexity and made it tough to stay current. For patients, the extra costs can be prohibitive. Learn how to stay abreast of the requirements and engage patients on the issue.
https://immattersacp.org/archives/2013/09/vaccines.htm
1 Sep 2013
Advice on monoclonal antibodies; new data on long-term COVID-19 symptoms, vaccine efficacy
The NIH offered guidance on prioritization when monoclonal antibodies can't be given to all eligible patients. Two studies looked at patients with persistent COVID-19 symptoms, and other research confirmed the safety and effectiveness of the vaccines, even with the delta variant.
https://immattersacp.org/weekly/archives/2021/09/14/2.htm
14 Sep 2021
Looking ahead at the past
ACP membership inspires through its principles, opportunities, and relevance.
https://immattersacp.org/archives/2024/01/looking-ahead-at-the-past.htm
1 Jan 2024
CDC and FDA weigh in on safety of bivalent vaccine; research examines COVID-19 sequelae, omicron variants
The CDC and FDA said an observed association of ischemic stroke with the Pfizer-BioNTech bivalent booster is very unlikely to represent a true clinical risk. New studies reported on symptoms a year after mild COVID-19 and estimated protection against the omicron variants.
https://immattersacp.org/weekly/archives/2023/01/24/2.htm
24 Jan 2023
Can medical practices provide vaccine incentives?
During the COVID-19 public health emergency, clinicians and organizations can temporarily offer incentives to get people vaccinated without violating federal anti-kickback statutes if certain safeguards are met.
https://immattersacp.org/archives/2021/10/can-medical-practices-provide-vaccine-incentives.htm
1 Oct 2021
COVID-19 Vaccine Forum: What Physicians Need to Know
The Oct. 16 forum hosted by ACP and Annals of Internal Medicine will feature a panel of experts including Anthony S. Fauci, MD, MACP.
https://immattersacp.org/weekly/archives/2020/10/06/2.htm
6 Oct 2020
Preparing today for tomorrow's potential pandemic
We all have a responsibility to reflect on our experiences with COVID-19 to identify both the good and the bad, assess the current state of pandemic preparedness, and implement a comprehensive plan.
https://immattersacp.org/archives/2023/09/preparing-today-for-tomorrows-potential-pandemic.htm
1 Sep 2023